Results 81 to 90 of about 3,209 (136)

Structure and Reaction Mechanism in the Heme Dioxygenases [PDF]

, 2011
Ames B. D., Austin C. J. D., Basran J., Batabyal D., Batabyal D., Cady S. G., Capece L., Capece L., Chauhan N., Chauhan N., Chen H., Christopher G. Mowat, Chung L. W., Chung L. W., Davydov R. M., Dawson J. H., DeLano W. L., Denisov I. G., Dick R., Dunford H. B., Dunford H. B., Emma Lloyd Raven, Erman J. E., Eser B. E., Forouhar F., Fukumura E., Guallar V., Gupta R., Hamilton G. A., Hayaishi O., Hu X., Igor Efimov, Jaswir Basran, Joule J. A., Knox W. E., Kotake Y., Kovaleva E. G., Leeds J. M., Lewis-Ballester A., Li J. S., Littlejohn T. K., Littlejohn T. K., Maghzal G. J., Manandhar S. P., Matsui T., Matsui T., Ortiz de Montellano P., Ortiz de Montellano P. R., Ortiz de Montellano P. R., Paglino A., Papadopoulou N. D., Ren S., Sandeep Handa, Sarah J. Thackray, Savige W. E., Sono M., Sono M., Springer B. A., Sugimoto H., Suzuki T., Tanaka T., Terentis A. C., Thackray S. J., Vottero E., Yagil G., Yamamoto S., Yamane T., Yanagisawa S., Yanagisawa S., Zhang Y., Zhu X., Zhu Y.   +71 more
core   +2 more sources

Boron-Based Functionalities Enhance, the Potency of 2,5-Dimethylfuran-Based IDO1 Inhibitors. [PDF]

Chembiochem
Carraro TJC, Dasgupta S, Ku J, Thomas SR, Rendina LM.   +4 more
europepmc   +1 more source

Zn⁶⁴ aspartate modulates inflammation, tryptophan metabolism, and pancreatic function in diet-induced obesity. [PDF]

Sci Rep
Temnik M, Gurin S, Magidenko L, Balakin A, Byshovets R, Kalmukova O, Vovk T, Halenova T, Raksha N, Savchuk O.   +9 more
europepmc   +1 more source

Not Indolamine 2,3-Dioxygenase Polymorphisms, but Low Levels of Indoleamine 2,3-Dioxygenase and IDO2 Are Associated with Behçet's Syndrome. [PDF]

Med Princ Pract
Oral HB, Uçar Ü, Atalay YA, Özkaya G, Oral HB.   +4 more
europepmc   +1 more source

Regulation of dendritic cell immune function and maturation by the recombinant antigen p53 of Trichinella spiralis. [PDF]

Parasit Vectors
Yuan X, Yang X, Han C.
europepmc   +1 more source

A selective IDO1 inhibitor, KHK2455, improves efficacy of PD-L1 blockade by modulating both innate and adaptive immunity in a mouse melanoma model. [PDF]

Cancer Immunol Immunother
Saito M, Kunieda K, Ishii T, Koshiba S, Ohashi R, Kanda Y, Yamada T.   +6 more
europepmc   +1 more source

IDO2-AhR axis as central regulator of the kynurenine pathway in glioblastoma. [PDF]

J Neurooncol
Jacquerie A, Macamo A, Hoeben A, Eekers DBP, Postma AA, Vanmechelen M, De Smet F, Ackermans L, Anten M, Verduin M, Severens K, Zur Hausen A, Beckervordersandforth J, Broen MPG.   +13 more
europepmc   +1 more source

Engineered red blood cell extracellular vesicles for delivery of Dox and siIDO1 enhance targeted chemo-immunotherapy of acute myeloid leukemia. [PDF]

J Immunother Cancer
Liu Y, Hu J, Shu Y, Li G, Jin F, Ren J, Yang J, Lin C, Tang L, Wei X, Sun M, Chen X, Wu N, Yang Z, Li Z, Zhang L.   +15 more
europepmc   +1 more source

Quercetin inhibits gastric cancer cell proliferation and migration and is associated with the suppression of the IDO1-Kynurenine-AhR axis. [PDF]

BMC Cancer
Zhu M, Hu Q, Lu Y, Xu Q, Huang H, Chen K, Shuai X, Wang Y, Huang J, Guo Z.   +9 more
europepmc   +1 more source

Peripheral Kynurenine Pathway Metabolites in Patients with Psoriasis. [PDF]

Int J Mol Sci
Stepaniuk A, Baran A, Hermanowicz JM, Sieklucka B, Pawlak D, Flisiak I.   +5 more
europepmc   +1 more source